XML 50 R34.htm IDEA: XBRL DOCUMENT v3.6.0.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
1 Months Ended 9 Months Ended 12 Months Ended
Jan. 31, 2017
USD ($)
shares
Sep. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Number
shares
Dec. 31, 2015
USD ($)
shares
Dec. 31, 2014
USD ($)
shares
Federal insurance limits     $ 250,000    
Number of issued patents | Number     17    
Advertising costs     $ 752,611 $ 792,574 $ 698,871
Shelf life of prescription products     24 months    
Number of operating segment | Number     1    
Shares issued for exercise of warrants, net     $ 1,373,000 $ 366,000 $ 181,000
Warrants [Member]          
Shares issued for exercise of warrants, net (in shares) | shares     722,744 945,485 365,583
Shares issued for exercise of warrants, net     $ 1,373,000 $ 366,000 $ 181,000
Subsequent Event [Member] | Warrants [Member]          
Shares issued for exercise of warrants, net (in shares) | shares 1,800,000        
Shares issued for exercise of warrants, net $ 2,436,000        
Two Customers [Member]          
Wrote off accounts receivable   $ 2,200,000      
Customer A [Member] | Accounts Receivable [Member]          
Concentration risk     28.00% 27.00%  
Customer B [Member] | Accounts Receivable [Member]          
Concentration risk     20.00% 30.00%  
Customer C [Member] | Accounts Receivable [Member]          
Concentration risk       14.00%  
Related to Research and Development Activities [Member]          
Advance payments - total     $ 228,933 $ 1,138,073  
Advance payments - other assets current       1,009,175  
Advance payments - long term prepaid expense       $ 128,898  
Minimum [Member]          
Estimated useful lives     3 years    
Return period of unsalable prescription products     6 months    
Minimum [Member] | Software [Member]          
Estimated useful lives     5 years    
Maximum [Member]          
Estimated useful lives     7 years    
Return period of unsalable prescription products     12 months    
Maximum [Member] | Software [Member]          
Estimated useful lives     7 years